FFA
RCKT icon

Farther Finance Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Farther Finance Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.04K Sell
2,655
-370
-12% -$1.23K ﹤0.01% 4487
2026
Q1 		$11K Buy
3,025
+1,273
+73% +$5.06K ﹤0.01% 4048
2025
Q4 		$6.15K Sell
1,752
-774
-31% -$2.65K ﹤0.01% 4188
2025
Q3 		$8.23K Sell
2,526
-11,014
-81% -$34.7K ﹤0.01% 3529
2025
Q2 		$33.2K Buy
13,540
+13,369
+7,818% +$67.7K ﹤0.01% 2356
2025
Q1 		$994 Buy
171
+94
+122% +$929 ﹤0.01% 3615
2024
Q4 		$968 Sell
77
-25
-25% -$376 ﹤0.01% 3261
2024
Q3 		$1.88K Sell
102
-3
-3% -$61 ﹤0.01% 3016
2024
Q2 		$2.17K Hold
105
– – ﹤0.01% 2761
2024
Q1 		$2.81K Hold
105
– – ﹤0.01% 2347
2023
Q4 		$3.15K Buy
105
+100
+2,000% +$2.21K ﹤0.01% 2211
2023
Q3 		$102 Buy
+5
New +$91 ﹤0.01% 2543

Other funds holding RCKT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OCWP
Owl Creek Wealth Partners Denver, Colorado $342M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's RCKT Position: Q2 2026 in Review

Farther Finance Advisors reduced its Rocket Pharmaceuticals (RCKT) stake by 12% in Q2 2026, selling an estimated $1.23K and leaving 2,655 shares worth $9.04K. The position accounts for ﹤0.01% of the portfolio, ranked #4487.

Farther Finance Advisors first reported a position in RCKT in Q3 2023 and has held it in 12 quarters since. The position peaked at $33.2K in Q2 2025. 14 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Farther Finance Advisors held 2,655 shares of Rocket Pharmaceuticals worth $9.04K as of Q2 2026.
  • Farther Finance Advisors sold 370 Rocket Pharmaceuticals shares in Q2 2026, an estimated $1.23K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4487 holding.
  • Farther Finance Advisors first reported a position in Rocket Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Rocket Pharmaceuticals position peaked at $33.2K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.